214 related articles for article (PubMed ID: 25142233)
21. Antibody response to HER2 extracellular domain and subdomains in mouse following DNA immunization.
Sadri-Ardalani F; Shabani M; Amiri MM; Bahadori M; Emami S; Sarrafzadeh AR; Noutash-Haghighat F; Jeddi-Tehrani M; Shokri F
Tumour Biol; 2016 Jan; 37(1):1217-27. PubMed ID: 26282003
[TBL] [Abstract][Full Text] [Related]
22. Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens.
Caro-Aguilar I; Rodríguez A; Calvo-Calle JM; Guzmán F; De la Vega P; Patarroyo ME; Galinski MR; Moreno A
Infect Immun; 2002 Jul; 70(7):3479-92. PubMed ID: 12065487
[TBL] [Abstract][Full Text] [Related]
23. Nitrated T helper cell epitopes enhance the immunogenicity of HER2 vaccine and induce anti-tumor immunity.
Tian H; He Y; Song X; Jiang L; Luo J; Xu Y; Zhang W; Gao X; Yao W
Cancer Lett; 2018 Aug; 430():79-87. PubMed ID: 29778570
[TBL] [Abstract][Full Text] [Related]
24. Differential antigenicity of recombinant polyepitope-antigens based on loop- and helix-forming B and T cell epitopes.
Theisen DM; Bouche FB; El Kasmi KC; von der Ahe I; Ammerlaan W; Demotz S; Muller CP
J Immunol Methods; 2000 Aug; 242(1-2):145-57. PubMed ID: 10986397
[TBL] [Abstract][Full Text] [Related]
25. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
Olszewska W; Obeid OE; Steward MW
Virology; 2000 Jun; 272(1):98-105. PubMed ID: 10873752
[TBL] [Abstract][Full Text] [Related]
26. Immunological analysis of the protective responses to the chimeric synthetic peptide representing T- and B-cell epitopes from the fusion protein of measles virus.
Obeid OE; Stanley CM; Steward MW
Virus Res; 1996 Jun; 42(1-2):173-80. PubMed ID: 8806185
[TBL] [Abstract][Full Text] [Related]
27. Construction and characterization of an HCV-derived multi-epitope peptide antigen containing B-cell HVR1 mimotopes and T-cell conserved epitopes.
Gao J; Gong Y; Zhao P; Zhu Q; Yang X; Qi Z
Sci China C Life Sci; 2006 Oct; 49(5):490-9. PubMed ID: 17172057
[TBL] [Abstract][Full Text] [Related]
28. Conformational HER-2/neu B-cell epitope peptide vaccine designed to incorporate two native disulfide bonds enhances tumor cell binding and antitumor activities.
Dakappagari NK; Lute KD; Rawale S; Steele JT; Allen SD; Phillips G; Reilly RT; Kaumaya PT
J Biol Chem; 2005 Jan; 280(1):54-63. PubMed ID: 15507452
[TBL] [Abstract][Full Text] [Related]
29. Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.
Obeid OE; Partidos CD; Howard CR; Steward MW
J Virol; 1995 Mar; 69(3):1420-8. PubMed ID: 7531779
[TBL] [Abstract][Full Text] [Related]
30. Chimeric T helper-B cell peptides induce protective response against Japanese encephalitis virus in mice.
Dewasthaly SS; Bhonde GS; Shankarraman V; Biswas SM; Ayachit VM; Gore MM
Protein Pept Lett; 2007; 14(6):543-51. PubMed ID: 17627594
[TBL] [Abstract][Full Text] [Related]
31. A novel multi-epitope peptide vaccine against cancer: an in silico approach.
Nezafat N; Ghasemi Y; Javadi G; Khoshnoud MJ; Omidinia E
J Theor Biol; 2014 May; 349():121-34. PubMed ID: 24512916
[TBL] [Abstract][Full Text] [Related]
32. Identification of epitope regions recognized by tumor inhibitory and stimulatory anti-ErbB-2 monoclonal antibodies: implications for vaccine design.
Yip YL; Smith G; Koch J; Dübel S; Ward RL
J Immunol; 2001 Apr; 166(8):5271-8. PubMed ID: 11290813
[TBL] [Abstract][Full Text] [Related]
33. Polyclonal Antibody against Different Extracellular Subdomains of HER2 Induces Tumor Growth Inhibition in vitro.
Hosseini Ghatar R; Soltantoyeh T; Bahadori M; Khoshnoodi J; Golsaz Shirazi F; Jeddi Tehrani M; Amiri MM; Shokri F
Iran J Immunol; 2017 Sep; 14(3):200-214. PubMed ID: 28919583
[TBL] [Abstract][Full Text] [Related]
34. Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice.
Wang B; Zaidi N; He LZ; Zhang L; Kuroiwa JM; Keler T; Steinman RM
Breast Cancer Res; 2012 Mar; 14(2):R39. PubMed ID: 22397502
[TBL] [Abstract][Full Text] [Related]
35. Structural and immunogenicity analysis of chimeric B-cell epitope constructs derived from the gp46 and gp21 subunits of the envelope glycoproteins of HTLV-1.
Sundaram R; Beebe M; Kaumaya PT
J Pept Res; 2004 Feb; 63(2):132-40. PubMed ID: 15009534
[TBL] [Abstract][Full Text] [Related]
36. Obtaining and characterization of monoclonal antibodies against recombinant extracellular domain of human epidermal growth factor receptor 2.
Sarina N; Abeldenov S; Turgimbayeva A; Zhylkibayev A; Ramankulov Y; Khassenov B; Eskendirova S
Hum Antibodies; 2018 Feb; 26(2):103-111. PubMed ID: 29036807
[TBL] [Abstract][Full Text] [Related]
37. Essential roles of tumor-derived helper T cell epitopes for an effective peptide-based tumor vaccine.
Wang L; Miyahara Y; Kato T; Wang L; Aota T; Kuribayashi K; Shiku H
Cancer Immun; 2003 Nov; 3():16. PubMed ID: 14629132
[TBL] [Abstract][Full Text] [Related]
38. Toxoplasma gondii-Derived Synthetic Peptides Containing B- and T-Cell Epitopes from GRA2 Protein Are Able to Enhance Mice Survival in a Model of Experimental Toxoplasmosis.
Bastos LM; Macêdo AG; Silva MV; Santiago FM; Ramos EL; Santos FA; Pirovani CP; Goulart LR; Mineo TW; Mineo JR
Front Cell Infect Microbiol; 2016; 6():59. PubMed ID: 27313992
[TBL] [Abstract][Full Text] [Related]
39. In silico proteomic characterization of human epidermal growth factor receptor 2 (HER-2) for the mapping of high affinity antigenic determinants against breast cancer.
Baloria U; Akhoon BA; Gupta SK; Sharma S; Verma V
Amino Acids; 2012 Apr; 42(4):1349-60. PubMed ID: 21229277
[TBL] [Abstract][Full Text] [Related]
40. Construction and characterization of a new chimeric antibody against HER2.
Amiri MM; Jeddi-Tehrani M; Kazemi T; Bahadori M; Maddah M; Hojjat-Farsangi M; Khoshnoodi J; Rabbani H; Shokri F
Immunotherapy; 2013 Jul; 5(7):703-15. PubMed ID: 23829622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
